今晚精准一码138-免费公开资料大全

09/2022

Portfolio News
CanSinoBIO's Convidecia Air™ Receives Approval in China
Portfolio News
Antengene Announces XPOVIO® Included for Reimbursement by the PBS in Australia
Portfolio News
Gan & Lee's GZR4 Completed the First Subject Administration in Phase I Clinical Trial

08/2022

Portfolio News
Atom Semiconductor and DP Technology were Included in Forbes Asia 100 To Watch 2022
Portfolio News
Prismlab Completes Series C Financing of 200m RMB Led by Qiming Venture Partners
Portfolio News
Belief BioMed's BBM-H901 Injection Receives China CDE's Breakthrough Therapy Designation
Portfolio News
DeepWay Completes Series A Round of 460m RMB Led by Qiming Venture Partners
Portfolio News
ZhenGe Biotech Announced the Completion of 100m RMB Series C+ Funding
Portfolio News
Several Key Research Supported by Amoy Diagnostics were Presented at WCLC 2022
Portfolio News
CanSinoBIO's Convidecia Air™ Receives Clinical Trial Approval in Malaysia
Portfolio News
Belief BioMed's BBM-H901 Injection was Granted Orphan Drug Designation by FDA
Portfolio News
Asieris' Multinational Phase III Clinical Trial Has Completed Enrollment
Portfolio News
Insta360 Launches AI-powered 4K Camera Link to Redefine Remote Work
Portfolio News
GluBio Completes Series A+ Round of $22m to Advance Development of Novel TPD Drugs
Portfolio News
OriCell Therapeutics Raises Over $120m in Series B Financing

07/2022

Portfolio News
Chatail Completes Series B Financing Round Led by Qiming Venture Partners
Portfolio News
Qiming's Portfolio Company InventisBio Lists on STAR Market

06/2022

Portfolio News
OriCell Reports OriCAR-017 Phase I POLARIS study Data in Oral Presentation at American Society of Clinical Oncology (ASCO) Annual Meeting 2022

05/2022

04/2022

Portfolio News
WeRide announces self-driving Robosweepers roll off the assembly line
Portfolio News
VenusP-Valve™ obtains CE marking under MDR and debuts in Europe as China's first valve product

03/2022

Portfolio News
Qiming’s Portfolio Company Rendu Biotechnology Lists on STAR Market
Portfolio News
Qiming’s Portfolio Company Arrail Group Lists on Main Board of HKEX

02/2022

Portfolio News
Convidecia Approved as Heterologous Booster in China
Portfolio News
Pluslife Biotech – A Greater Bay Area Company Launches First Handheld Covid-19 Nucleic Acid Test

01/2022

Portfolio News
Qiming’s Portfolio Company Asieris Pharmaceuticals Lands on STAR Market

10/2021

Portfolio News
Beijing’ Covid Booster Campaign Includes Cansino’s Vaccine: Bloomberg
Portfolio News
ShouTi Secures $100 Million Series B Financing, Qiming Participated
Portfolio News
WeRide unveils China's first Level 4 self-driving cargo van
Portfolio News
Geneseeq and Zai Lab Announce Strategic Collaboration to Advance Cancer Drug R&D
Portfolio News
Qiming’s Portfolio Company Microtech Medical Lists on Main Board of HKEx
Portfolio News
Qiming’s Portfolio Company Abbisko Lists on Main Board of HKEx

09/2021

Portfolio News
Qiming’s Portfolio Company Broncus Lists on Main Board of HKEx
Portfolio News
Chinese driverless car firm WeRide launches ‘Robovan’ for autonomous deliveries: CNBC
Portfolio News
Indonesia approves J&J, Cansino COVID-19 vaccines for emergency use: Reuters
Portfolio News
CanSino booster shot increases antibodies 78-fold
Portfolio News
Alamar Biosciences Completes $80M Series B Fundraising to Bring Unprecedented Performance to the Proteomics Market

08/2021

Portfolio News
‘AI doctor’developer Zuoshouyisheng raises USD 15.5 million in Series B: KrAsia
Portfolio News
Blockchain Startup InfStones Raises $10M in Series A Funding Round: CoinDesk
Portfolio News
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO® (tepotinib)
Portfolio News
China's mRNA vaccine technology firm Abogen raises over $700 mln: Reuters
Portfolio News
InferVision AI Assists the European Commission Monitoring COVID-19 Variants
Portfolio News
InferVision Completes Series D2 Financing Round
Portfolio News
Qiming’s Portfolio Company Sino Biological Lists on Shenzhen’s ChiNext Market
Portfolio News
New Milestone in Kidney Fibrosis: AI-designed Pipeline of Antifibrotic Therapies – Insilico
Portfolio News
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval
Portfolio News
Antengene, MindRank AI to Jointly Develope Difficult-to-Drug Molecular Targets
Portfolio News
Berry Oncology Completes Series B1 Funding
Portfolio News
Asia's Leading Crypto Financial Services Platform Matrixport Valued at Over $1 Billion
Portfolio News
Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma

07/2021

Pages